Phase 3 Mosaic-Based Investigational HIV Vaccine Study Discontinued Following Disappointing Results of Planned Data Review

Phase 3 Mosaic-Based Investigational HIV Vaccine Study Discontinued Following Disappointing Results of Planned Data Review

HVTN researchers and ethicists say findings will help guide new approaches to HIV vaccine studies
News Releases - January 18, 2023
Faith Forward 2030

Faith Forward 2030

Fighting for Our Lives
Community Compass - December 12, 2022
Communities of Faith Breakfast

Communities of Faith Breakfast

Building Partnerships for a One-Community Response to HIV
Community Compass - December 12, 2022
Dr. Larry Corey receives Alexander Fleming Award

Dr. Larry Corey receives Alexander Fleming Award

Virologist honored by peers for his lifetime achievements against infectious diseases
Community Compass - December 12, 2022
HVTN Profiles

HVTN Profiles

Community Compass - December 12, 2022
Newly defined biomarker may accelerate clinical trials for vaccines to prevent HIV-1 infection

Newly defined biomarker may accelerate clinical trials for vaccines to prevent HIV-1 infection

A study published in the Aug. 22, 2022 issue of Nature Medicine identifies a new biomarker that appears effective as a surrogate endpoint to reliably predict the ability of broadly neutralizing monoclonal antibodies to prevent acquisition of HIV-1, the most common type of the virus that causes AIDS.
News Releases - August 24, 2022
HVTN at the 24th International AIDS Conference in Montreal

HVTN at the 24th International AIDS Conference in Montreal

HVTN researchers and faith leaders will address HIV and SARS-CoV-2, neutralizing antibodies, future directions for research, lessons from COVID-19 community engagement, overcoming HIV stigma and discrimination, and more
News Releases - July 28, 2022

News on HVTN

Read MORE
Year in Pictures: 2022 A look back at the year through compelling images December 12, 2022
Could a 100-year-old TB vaccine help scientists find a better one? Harmless vaccine BCG is made of living bacteria; in tests might serve as a proxy for deadly tuberculosis December 12, 2022
Dr. Larry Corey receives Alexander Fleming Award Virologist honored by peers for his lifetime achievements against infectious diseases October 21, 2022
Fauci visits Fred Hutch, discusses pandemics, vaccines and scientific misinformation NIAID director’s determined spirit recognized with honorary Hutch Award August 10, 2022